Skip to main content

Table 2 Patient characteristics in the SOS study

From: A SNP in the 5’ flanking region of the SAA1 gene is associated with serum levels of serum amyloid A and cardiovascular risk factors

 

C/C

C/T or T/T

p-value

Number

3146

396

 

Age, years

47.9 ± 6.1

47.9 ± 6.1

0.870

Male sex, n (%)

948 (30.1)

112 (28.3)

0.485

BMI, kg/m2

41.2 ± 4.7

41.3 ± 4.8

0.761

Weight, kg

117.9 ± 16.9

117.1 ± 16.4

0.363

Height, cm

169.1 ± 9.2

168.4 ± 9.3

0.093

Sagittal diameter, cm

28.1 ± 3.7

28.0 ± 3.8

0.536

P-glucose, mmol/L

5.65 ± 2.14

5.86 ± 2.40

0.0545

S-insulin, mIU/L

19.71 ± 12.96

19.85 ± 11.67

0.452

HOMA-IR

5.24 ± 5.00

5.56 ± 5.80

0.169

Diabetes, n (%)

474 (15.1)

64 (16.2)

0.553

S-Cholesterol, mmol/L

5.73 ± 1.09

5.80 ± 1.16

0.312

S-HDL cholesterol, mmol/L

1.36 ± 0.33

1.31 ± 0.30

0.0148

ApoA1, g/L

1.41 ± 0.25

1.39 ± 0.22

0.259

ApoB, g/L

1.27 ± 0.30

1.29 ± 0.31

0.181

ApoE, g/L

0.061 ± 0.044

0.066 ± 0.064

0.0280

S-triglycerides, mmol/L

2.14 ± 1.54

2.25 ± 1.56

0.0418

Systolic blood pressure, mmHg

142 ± 19

141 ± 18

0.916

Diastolic blood pressure, mmHg

88 ± 11

87 ± 11

0.893

  1. Differences between T-allele carriers and C allele homozygotes were analyzed with independent T-test or Fisher’s exact test for dichotomous variables. Continuous variables were box cox transformed to achieve normal distribution before analysis